Complete Genome Sequence of the Goatpox Virus Strain Gorgan Obtained Directly from a Commercial Live Attenuated Vaccine

Elisabeth Mathijs; Frank Vandenbussche; Andy Haegeman; Ahmad Al-Majali; Kris De Clercq; Steven Van Borm

doi:10.1128/genomeA.01113-16

Complete Genome Sequence of the Goatpox Virus Strain Gorgan Obtained Directly from a Commercial Live Attenuated Vaccine

Genome Announc. 2016 Oct 13;4(5):e01113-16. doi: 10.1128/genomeA.01113-16.

Authors

Elisabeth Mathijs¹, Frank Vandenbussche¹, Andy Haegeman², Ahmad Al-Majali³, Kris De Clercq², Steven Van Borm⁴

Affiliations

¹ Molecular Platform, Veterinary and Agrochemical Research Centre, Ukkel, Belgium.
² Viral Diseases, Vesicular and Exotic Diseases, Veterinary and Agrochemical Research Centre, Ukkel, Belgium.
³ Jordan Bio-Industries Centre (JOVAC), Amman, Jordan Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.
⁴ Molecular Platform, Veterinary and Agrochemical Research Centre, Ukkel, Belgium steven.vanborm@coda-cerva.be.

Abstract

This is a report of the complete genome sequence of the goatpox virus strain Gorgan, which was obtained directly from a commercial live attenuated vaccine (Caprivac, Jordan Bio-Industries Centre).

Grants and funding

The research that yielded these results was funded by the Bill and Melinda Gates Foundation (grant agreement; Investment ID OPP1126866), the European Union FP7 project RAPIDIA-FIELD (grant number FP7-289364), the Belgian Federal Public Service of Health, Food Chain Safety and Environment through the contract RT 15/3 LUMPY SKIN 1, and the Veterinary and Agrochemical Research Centre (CODA-CERVA), Ukkel, Belgium.